SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEKÂ 478.80
arrow_downward
-0.29%(-1.40) 1D
Nov 17, 9:49:46 AM GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEKÂ 476.00
High
SEKÂ 479.00
Low
SEKÂ 475.20
Mkt. cap
171.24B
Avg. vol.
428.81K
Volume
11.00K
P/E ratio
25.43
52-wk high
SEKÂ 507.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 18.83
Shares outstanding
357.64M
No. of employees
2K
Open
SEKÂ 476.00
High
SEKÂ 479.00
Low
SEKÂ 475.20
Mkt. cap
171.24B
Avg. vol.
428.81K
Volume
11.00K
P/E ratio
25.43
52-wk high
SEKÂ 507.00
52-wk low
SEKÂ 314.40
EPS
SEKÂ 18.83
Shares outstanding
357.64M
No. of employees
2K
News stories
From web sources and news partners
Seeking Alpha
·
46 minutes ago
RDVI: The Dividend ETF Beating The S&P 500, And Almost Nobody Knows How (Rating Upgrade)
Reuters
·
9 hours ago
Wall Street ends sharply lower on AI jitters ahead of Nvidia results, Anthropic IPO
Yahoo Finance
·
2 hours ago
Stock Market: Will S&P 500 Open Up or Down Today?
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)
CEOGuido Oelkers
Employees2.21K
Founded1939
Headquarters-
SectorHealth Care
IndustryBiotechnology
Websitesobi.com